Elimination of CD20-Expressing Cells in Multiple Myeloma by Iodine I-131 Tositumomab (Bexxar®) Correlates with Response to Therapy
Year: 2008
Type: article
Study design: Clinical Trial
Source: Blood
Institutions: University of Michigan, U-M Rogel Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2558022946
